Advanced Cardiovascular POC Testing System Gets FDA Clearance
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Next-gen cardiometabolic biomarkers will aid earlier detection of risk factors for obesity, diabetes, and heart disease in children.
CardioMetaboliQ, an at-home blood test that empowers users to support their cardiovascular and metabolic health, is available to consumers.
Researchers found that CoDE-ACS was able to rule out a heart attack in more than double the number of patients, with an accuracy of 99.6%.
Read MoreThe BNP control is designed to be used alongside the Acusera range of third-party controls, providing a comprehensive package.
Read MoreThe new CONNEQT Pulse is a customizable vascular biometric monitor that provides medical grade arterial heart health metrics.
Read MoreIllumina and Henry Ford Health launched a partnership to assess the impact of comprehensive genomic testing in cardiovascular disease.
Read MoreBio-Rad has launched its newest cardiac control product, Cardiac Advance, to monitor the precision of instrument testing for cardiac events.
Read MoreA new proteomic risk model for cardiovascular disease was found to be more accurate than current methods of measuring cardiac risk
Read MoreEko, a digital health company applying AI to address heart and lung disease, has launched the SENSORA Cardiac Disease Detection Platform.
Read MoreProterixBio’s ST2 Assay is for use in conjunction with clinical evaluation in assessing the prognosis of patients with chronic heart failure.
Read MoreCareDx announced the publication of International Society for Heart and Lung Transplantation guidelines supporting its surveillance portfolio.
Read MoreMade of graphene, the device is worn on the wrist and can measure blood pressure with comparable accuracy to a standard blood pressure cuff.
Read MoreResearchers devised a new biomarker-based strategy to screen for a deadly complication caused by monoclonal antibodies used to treat cancer.
Read MoreNeuome Peptides Pte. established an assay-development platform for the quantifiable detection of biomarkers.
Read MoreThe method uses molecular profiling and AI to develop dietary signatures to predict cardiovascular disease and type 2 diabetes risks.
Read MoreHigh-density lipoprotein cholesterol may not be as effective as scientists once believed in predicting cardiovascular disease risks.
Read MoreClinicians who were high adopters of AI-enabled clinical decision support tools efficiently diagnosed low left ventricular ejection fraction.
Read More